Rolf C R Ljung (Rolf Ljung)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

European journal of haematology

PloS one

British journal of haematology

Lund University Medical Faculty Foundation

Lund University Medical Faculty Foundation (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lund University Medical Faculty Foundation Dec 01 2009

Sweden

Professor :: Dept. of Clinical Sciences Lund

Education History

Lund University Medical Faculty Foundation Sep 01 1969 - Jan 10 1975

Sweden

PHD :: Dept. of Clinical Sciences Lund

Publications

Rolf C R Ljung, Davide Matino, Amy D Shapiro
Recombinant factor IX Fc for the treatment of hemophilia B. European journal of haematology 112 (5) (2024)
Björn Lundin, Nihal Bakeer, Amy L Dunn, Sridhar Gibikote, Shyamkumar N Keshava, Rolf C R Ljung, Olympia Papakonstantinou, Helen Pergantou, Karen Strike, Annette von Drygalski, Ningning Zhang, Paul Babyn, Saunya Dover, Andrea Schwarz Doria
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Annika Mårtensson, Anna Letelier, Eric Manderstedt, Heidi Glosli, Rolf C R Ljung
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Rolf C R Ljung, Davide Matino, Amy D Shapiro
Recombinant factor IX Fc for the treatment of hemophilia B. European journal of haematology (2024)
Björn Lundin, Nihal Bakeer, Amy L Dunn, Sridhar Gibikote, Shyamkumar N Keshava, Rolf C R Ljung, Olympia Papakonstantinou, Helen Pergantou, Karen Strike, Annette von Drygalski, Ningning Zhang, Paul Babyn, Saunya Dover, Andrea Schwarz Doria
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Rolf C R Ljung, Davide Matino, Amy D Shapiro
Recombinant factor IX Fc for the treatment of hemophilia B. European journal of haematology 112 (5) (2024)
Annika Mårtensson, Anna Letelier, Eric Manderstedt, Heidi Glosli, Rolf C R Ljung
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Hanjing Xie, Rolf C R Ljung, Jan Astermark, Terese Hylander
Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 28 (6) (2022)
Rolf C R Ljung, Marloes de Kovel, H Marijke van den Berg, null null
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2022)
Björn Lundin, Fariba Baghaei, Margareta Holmström, Pia Petrini, Gunilla Müller, Sven Månsson, Rolf C R Ljung
Haemophilia A and B - evaluation of the Swedish prophylactic regimen by magnetic resonance imaging. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Rolf C R Ljung, Marloes de Kovel, H Marijke van den Berg, null null
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2022)
Rolf C R Ljung, Marloes de Kovel, H Marijke van den Berg, null null
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Rolf C R Ljung, Marloes de Kovel, H Marijke van den Berg, null null
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2022)
Rolf C R Ljung
Registries and databases-A European perspective. Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Eric Manderstedt, Christina Lind-Halldén, Rolf C R Ljung, Jan Astermark, Christer Halldén
Identification of F8 rearrangements in carrier and non-carrier mothers of haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Victor Jimenez Yuste, Günter Auerswald, Gary Benson, Gerry Dolan, Cedric Hermans, Thierry Lambert, Rolf C R Ljung, Massimo Morfini, Elena Santagostino, Silva Zupančić Šalek
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Nadine G Andersson, Maria Rossing, Marcus Fager Ferrari, Migle Gabrielaite, Eva Leinøe, Rolf C R Ljung, Annika Mårtensson, Eva Norström, Eva M K Zetterberg
Genetic screening of children with suspected inherited bleeding disorders. Haemophilia : the official journal of the World Federation of Hemophilia 26 (2) (2020)
H Marijke van den Berg, Kathelijn Fischer, Manuel Carcao, Hervé Chambost, Gili Kenet, Karin Kurnik, Chris Königs, Christoph Male, Elena Santagostino, Rolf C R Ljung, null null
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A. Blood 134 (3) (2019)
Eric Manderstedt, Rosanna Nilsson, Christina Lind-Halldén, Rolf C R Ljung, Jan Astermark, Christer Halldén
Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening. PloS one 14 (4) (2019)
Rolf C R Ljung
Prevention and Management of Bleeding Episodes in Children with Hemophilia. Paediatric drugs 20 (5) (2018)
Rolf C R Ljung
How I manage patients with inherited haemophilia A and B and factor inhibitors. British journal of haematology 180 (4) (2017)

Rolf C R Ljung.css-eqlu8i{font-size:small;padding-left:4px;} (Rolf Ljung)

Publication Activity (10 Years)

Top Topics

Top Venues

Rolf C R Ljung (Rolf Ljung)